The role of serine metabolism on the evolution of oral squamous cell carcinoma
丝氨酸代谢在口腔鳞状细胞癌演变中的作用
基本信息
- 批准号:10825875
- 负责人:
- 金额:$ 4.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-12 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:Alcohol consumptionAlgorithmsAnabolismAnatomyBiochemicalBiologicalBiological AssayCarcinomaCell CommunicationCell Differentiation processCell LineCell LineageCellsChromatinChromatin StructureClinicalCluster AnalysisComplexCoupledDevelopmentDietary InterventionDifferentiated GeneDifferentiation AntigensDioxygenasesEnvironmentEnzymesEpigenetic ProcessEpitheliumEvolutionGenesGenomicsGlobal ChangeGrowthHead and Neck CancerHeterogeneityHistonesHumanHuman PapillomavirusImmunofluorescence ImmunologicImmunohistochemistryIn VitroInvadedIsogenic transplantationKnowledgeLeadLysineMalignant Epithelial CellMalignant NeoplasmsMesenchymalMessenger RNAMetabolismModelingModificationMorbidity - disease rateMorphologyNeoplasm MetastasisNuclearNutrientOperative Surgical ProceduresOutcomePathway interactionsPatientsPharmaceutical PreparationsPhenotypePlayPopulationProliferatingProliferation MarkerProteinsRadiation therapyRepressionResearchResistanceRoleScienceSerineSignal PathwayStarvationTherapeuticTobacco useTranscription Initiation SiteValidationWestern BlottingWithdrawaladvanced diseasealpha ketoglutaratecancer stem cellcancer therapycell motilitychemotherapycost effectivedemethylationdeprivationderepressiondietarydietary restrictionenzyme pathwayepigenomic profilingepigenomicshistone modificationin vivoinsightmalignant mouth neoplasmmigrationmortalitymouse modelmouth squamous cell carcinomaneoplastic cellnovelnovel therapeutic interventionnovel therapeuticsprecision nutritionprogramsresponseside effectstemstem cell genesstem cell populationstemnesssuccesstargeted treatmenttherapeutically effectivetraittreatment responsetumortumor growthtumor heterogeneitytumor progressiontumorigenicuptake
项目摘要
ABSTRACT
Oral squamous cell carcinoma (OSCC) is a devastating malignancy associated with high morbidity, poor survival,
and few therapeutic options. OSCC is characterized by heterogeneous cell states, including cancer stem cells
(CSCs), which drive metastasis and therapy resistance. Although there has been some modest success with
targeted therapies, there remains a need for more effective therapeutic options for OSCC. Increasing evidence
has shown that changes in serine metabolism can direct cell fate via epigenomic changes. Endogenous serine
synthesis generates a by-product, alpha-ketoglutarate (αKG), which is a co-substrate for nuclear αKG-
dependent dioxygenases to demethylate histone marker H3K27me3 and de-repress differentiation genes. We
have shown that under serine starvation conditions, metastatic OSCC HSC3 cells slowed proliferation
concomitant with a change in morphology from mesenchymal to epithelial, compared to cells grown in complete
medium. This was associated with a statistically significant increase in the steady-state mRNA and enzyme
levels in the serine synthesis pathway under serine starvation conditions, indicating that HSC3 cells rely on
exogenous serine for growth. The observed switch from exogenous serine uptake to endogenous serine
synthesis in HSC3 cells was accompanied by an increase in αKG concentration. Furthermore, serine starvation
and increased αKG were associated with decrease of repressive histone marker H3K27me3, thus de-repressing
terminal epithelial differentiation genes. Simultaneously, there is a decrease in H3K4me3, a marker of open
chromatin structure, associated with the promotion of stemness genes and aggressive cancer traits in OSCC.
Initial studies into the plasticity of the stem-like identity using the tumorsphere formation assay shows that serine
starvation leads to a lack of tumorspheres stability. Our findings suggest that a switch from exogenous serine
uptake to the endogenous serine biosynthesis promotes OSCC cell differentiation concomitant with the loss of
CSC identity. Given my preliminary studies, I hypothesize that serine deprivation promotes epigenetic changes
that inhibit CSCs and OSCC progression to advanced disease. I will investigate our hypotheses through two
aims. My first aim will be to determine mechanisms underlying epigenetic modifications in a panel of OSCC cell
lines in response to serine deprivation in vitro. This will be investigated through use of migration and invasion
assays, in depth tumorsphere analysis, and epigenomic profiling. My second aim will be to define changes in
tumor size and tumor cell populations in response to dietary serine restriction in vivo, utilizing a syngeneic
4MOSC1 isograft mouse model of OSCC to interrogate the heterogeneity of tumor cell populations through
scRNAseq with biochemical validation. These studies will fill the gap in knowledge how changes in serine
metabolism impact the epigenomic environment and provide insight into novel therapeutic options for OSCC.
抽象的
口腔鳞状细胞癌(OSCC)是一种毁灭性的恶性肿瘤,发病率高、生存率低、
口腔鳞癌的治疗选择很少,其特点是细胞状态异质,包括癌症干细胞。
(CSC),它会导致转移和治疗耐药,尽管在这方面取得了一些成功。
靶向治疗,仍然需要更多有效的 OSCC 治疗选择。
研究表明,丝氨酸代谢的变化可以通过表观基因组的变化来指导细胞的命运。
合成会产生副产物 α-酮戊二酸 (αKG),它是核 αKG- 的共底物
依赖双加氧酶使组蛋白标记 H3K27me3 去甲基化并去抑制分化基因。
研究表明,在丝氨酸饥饿条件下,转移性 OSCC HSC3 细胞的增殖速度减慢
与完全生长的细胞相比,伴随着从间充质到上皮的形态变化
这与稳态 mRNA 和酶的统计显着增加有关。
丝氨酸饥饿条件下丝氨酸合成途径的水平,表明HSC3细胞依赖于
观察到的从外源丝氨酸摄取到内源丝氨酸的转变。
HSC3 细胞中的合成伴随着 αKG 浓度的增加此外,丝氨酸饥饿。
αKG 的增加与抑制性组蛋白标记物 H3K27me3 的减少相关,从而解除抑制
同时,开放标记 H3K4me3 也有所减少。
染色质结构,与 OSCC 中干性基因和侵袭性癌症特征的促进相关。
使用肿瘤球形成测定对茎样身份的可塑性进行的初步研究表明,丝氨酸
我们的研究结果表明,饥饿导致肿瘤球缺乏稳定性。
摄取内源丝氨酸生物合成促进 OSCC 细胞分化,同时丧失丝氨酸
根据我的初步研究,我发现丝氨酸剥夺会促进表观遗传变化。
抑制 CSC 和 OSCC 进展为晚期疾病,我将通过两个方面来研究我们的假设。
我的首要目标是确定一组 OSCC 细胞表观遗传修饰的机制。
体外对丝氨酸剥夺的反应这将通过使用迁移和入侵进行研究。
我的第二个目标是确定肿瘤领域的变化。
利用同源方法研究体内饮食丝氨酸限制对肿瘤大小和肿瘤细胞群的响应
4MOSC1同种移植OSCC小鼠模型通过以下方式探究肿瘤细胞群的异质性
这些研究将填补丝氨酸如何变化的知识空白。
代谢影响表观基因组环境,并为口腔鳞癌的新治疗选择提供见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stacy Jankowski其他文献
Stacy Jankowski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
地表与大气层顶短波辐射多分量一体化遥感反演算法研究
- 批准号:42371342
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
高速铁路柔性列车运行图集成优化模型及对偶分解算法
- 批准号:72361020
- 批准年份:2023
- 资助金额:27 万元
- 项目类别:地区科学基金项目
随机密度泛函理论的算法设计和分析
- 批准号:12371431
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
基于全息交通数据的高速公路大型货车运行风险识别算法及主动干预方法研究
- 批准号:52372329
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高效非完全信息对抗性团队博弈求解算法研究
- 批准号:62376073
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
Deciphering the Glycan Code in Human Alzheimer's Disease Brain
破译人类阿尔茨海默病大脑中的聚糖代码
- 批准号:
10704673 - 财政年份:2023
- 资助金额:
$ 4.85万 - 项目类别:
Deciphering microbial contribution to androgen bioavailability in castration resistant prostate cancer patients
破译微生物对去势抵抗性前列腺癌患者雄激素生物利用度的贡献
- 批准号:
10573918 - 财政年份:2023
- 资助金额:
$ 4.85万 - 项目类别:
Directed evolution of broadly fungible biosensors
广泛可替代生物传感器的定向进化
- 批准号:
10587024 - 财政年份:2023
- 资助金额:
$ 4.85万 - 项目类别:
Adaptive resistance to AR inhibitors in hypoxia by GPT1
GPT1对缺氧环境下AR抑制剂的适应性抵抗
- 批准号:
10638774 - 财政年份:2023
- 资助金额:
$ 4.85万 - 项目类别:
Synthesizability-constrained expansion and multi-objective evolution of antitubercular compounds
抗结核化合物的可合成性约束扩展和多目标进化
- 批准号:
10430402 - 财政年份:2022
- 资助金额:
$ 4.85万 - 项目类别: